⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CTXR News
Citius Pharmaceuticals Inc. Common
Form 8-K
sec.gov
CTXR
CTOR
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
prnewswire.com
CTXR
CTOR
Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
prnewswire.com
CTXR
CTOR
Form 8-K
sec.gov
CTXR
Form 8-K
sec.gov
CTOR
CTXR
Form 8-K
sec.gov
CTXR
CTOR
Citius Oncology Ships First International Order of LYMPHIR™ to Europe
prnewswire.com
CTXR
CTOR
Form 8-K
sec.gov
CTXR
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
prnewswire.com
CTXR
Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
prnewswire.com
CTXR